- Home
- MYNZ vs PETZ Comparison
MYNZ vs PETZ Comparison
Compare MYNZ & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MYNZ | PETZ |
|---|---|---|
| Founded | 2021 | 2002 |
| Country | Germany | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 10.0M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MYNZ | PETZ |
|---|---|---|
| Price | $1.18 | $1.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 369.5K | 9.9K |
| Earning Date | 12-29-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | $659,935.00 | ★ $1,046,006.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | ★ N/A | $6.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.92 | $0.65 |
| 52 Week High | $8.20 | $1.68 |
Technical Indicators
Market Signals| Indicator | MYNZ | PETZ |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 56.26 |
| Support Level | $1.12 | $0.90 |
| Resistance Level | $1.50 | $1.03 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 26.19 | 86.67 |
Price Performance
Historical ComparisonAbout MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.